Quick Answer
Cogent Biosciences, Inc. reported Net Income of -$328.94 million for fiscal year 2025.
Cogent Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$328.94M | -28.6% |
| 2024 | -$255.86M | -33.0% |
| 2023 | -$192.41M | -37.2% |
| 2022 | -$140.24M | -94.0% |
| 2021 | -$72.27M | +3.4% |
| 2020 | -$74.81M | -135.0% |
| 2019 | -$31.83M | +7.8% |
| 2018 | -$34.53M | -35.5% |
| 2017 | -$25.49M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$80.93M | -14.6% | -10.1% |
| June 30, 2025 | -$73.53M | -24.7% | -2.1% |
| March 31, 2025 | -$71.99M | -23.4% | -1.9% |
| September 30, 2024 | -$70.63M | -27.5% | -19.8% |
| June 30, 2024 | -$58.95M | -33.7% | -1.0% |
| March 31, 2024 | -$58.35M | -51.2% | -5.4% |
| September 30, 2023 | -$55.38M | -58.0% | -25.7% |
| June 30, 2023 | -$44.08M | -26.2% | -14.2% |
- Cogent Biosciences, Inc. showed a decrease of -28.6% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Cogent Biosciences, Inc.’s net income has declined by 1190.4% (from -$25.49 million to -$328.94 million).
- The most recent figure is from Cogent Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: